DTC Ads, Third-Party Audits Are CDRH Compliance Office Priorities In 2006
This article was originally published in The Gray Sheet
Executive Summary
FDA's device center is focused on ensuring that the most important risk information is disclosed in direct-to-consumer advertisements, according to CDRH Office of Compliance Director Tim Ulatowski